Генетические предикторы терапевтического ответа на препараты лития
https://doi.org/10.31363/2313-7053-2019-4-1-26-27
Аннотация
Об авторе
У. ХейлброннерГермания
Список литературы
1. Alda M., Manchia M. Personalized management of bipolar disorder. Neuroscience Lettersю 2018;669:3 – 9. https://doi.org/10.1016/j.neulet.2017.12.005
2. Garnham J., Munro A., Slaney C., Macdougall M., Passmore M., Duffy A., Alda M. Prophylactic treatment response in bipolar disorder: Results of a naturalistic observation study. Journal of Affective Disorders. 2007;104(1–3):185–190. https://doi. org/10.1016/j.jad.2007.03.003
3. Grof P., Duffy A., Cavazzoni P., Grof E., Garnham J., MacDougall M., Alda M. Is response to prophylactic lithium a familial trait? The Journal of Clinical Psychiatry. 2002;63(10):942–947. https:// doi.org/10.4088/jcp.v63n1013
4. Hou L., Heilbronner U., Degenhardt F., Adli M., Akiyama K., Akula N., Schulze, T. G. Genetic variants associated with response to lithium treatment in bipolar disorder: A genome-wide association study. The Lancet. 2016;387(10023):1085–1093. https://doi.org/10.1016/S0140-6736(16)00143-4
5. Papiol S., Schulze T. G., Alda M. Genetics of Lithium Response in Bipolar Disorder. Pharmacopsychiatry. 2018;51(5):206–211. https://doi. org/10.1055/a-0590-4992
6. Perlis R.H., Smoller J.W., Ferreira M.A.R., McQuillin A., Bass N., Lawrence J., Purcell S. A genomewide association study of response to lithium for prevention of recurrence in bipolardisorder. The American Journal of Psychiatry. 2009;166(6):718–725. https://doi.org/10.1176/appi. ajp.2009.08111633
7. Pisanu C., Heilbronner U., Squassina A. The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine. Mol Diagn Ther. 2018;22(4):409–420. https://doi.org/10.1007/ s40291-018-0335-y
8. Schulze T.G., Alda M., Adli M., Akula N., Ardau R., Bui E. T., … McMahon, F.J. The International Consortium on Lithium Genetics (ConLiGen): An initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. Neuropsychobiology. 2010;62(1):72–78. https://doi. org/10.1159/000314708
9. Song J., Bergen S. E., Di Florio A., Karlsson R., Charney A., Ruderfer D. M., Landén M. Genomewide association study identifies SESTD1 as a novel risk gene for lithium-responsive bipolar disorder. Molecular Psychiatry. 2017;22(8):1223. https://doi. org/10.1038/mp.2016.246
10. Squassina A., Manchia M., Borg J., Congiu D., Costa M., Georgitsi M., Patrinos G.P. Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder. Pharmacogenomics. 2011;12(11):1559–1569. https://doi.org/10.2217/ pgs.11.102
Рецензия
Для цитирования:
Хейлброннер У. Генетические предикторы терапевтического ответа на препараты лития. Обозрение психиатрии и медицинской психологии имени В.М.Бехтерева. 2019;(4-1):26-27. https://doi.org/10.31363/2313-7053-2019-4-1-26-27
For citation:
Heilbronner U. Genetic Predictors of Lithium Response. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY. 2019;(4-1):26-27. https://doi.org/10.31363/2313-7053-2019-4-1-26-27